Ganymed gains $82M in new round

Published on Tuesday 18 November 2008 - 16:14

Summary :
ATS Beteiligungsverwaltung has led an $82 million ( 65 million) round for Germany's Ganymed Pharmaceuticals. Future Capital joined the round with private investors as Ganymed prepares to enter the...
Read more

Information source

http://www.fiercebiotech.com/news/frontpage

Website description
Get the latest news on the biotech industry, biotech companies, FDA approval and clinical research. Sign up today for the biotech industry

Articles published on this website : 1 / 7 days - 4 / 30 days

FDA approves prostate cancer drug Degarelix Amgen files for crucial denosumab approval Synta gets $15M milestone from GSK AZ returns rights to two oncology programs OncoGenex shares soar on promising prostate cancer data

Other articles published on other websites on the same day

Diabetes drugs tied to lower prostate cancer risk http://www.reuters.com/ Aspirin May Lower PSA Levels in Men http://www.consumeraffairs.com/ Vitamin C and E Supplements Do Not Reduce Cancer Risk http://www.medscape.com/ AACR FCPR 2008: Vitamin C and E Supplements Do Not Reduce Cancer Risk http://www.medscape.com/ NSAIDs Lower PSA, But May Not Reduce Prostate Cancer Risk http://www.medscape.com/ AACR FCPR 2008: NSAIDs Lower PSA, But May Not Reduce Prostate Cancer Risk http://www.medscape.com/ Real Men Get Prostate Cancer http://well.blogs.nytimes.com/ Growing Number Of Young Prostate Cancer Patients Need 'sexual Rehabilitation' http://www.medicalnewstoday.com/ Significantly Lower PSA Levels Discovered In Men Who Take Aspirin http://www.medicalnewstoday.com/ MicroRNA Safety Switch Prevents Spread Of Cancer http://www.emaxhealth.com/